Sferalp will use Fluid Air’s PolarDry technology for powder processing.
Fluid Air, a division of Spraying Systems, announced that Sferalp, the R&D arm of Micro-Sphere, has selected their PolarDry technology for use in its research laboratory in Monteggio, Switzerland. Sferalp will use the PolarDry technology for powder processing with its commercial food, pharmaceutical, and nutraceutical customers.
“Our Swissmedic-certified laboratory is authorized to perform chemical-physical quality control tests on medicinal products and active substances in accordance with [good manufacturing practices] for medicinal products, and we know that we can count on Fluid Air technology to help achieve superior results for our customers,” said Michele Müller, general manager of Sferalp, in a May 10, 2022 company press release. “Fluid Air is the only provider in the marketplace whose technology can support our lab’s needs and help us meet the highest industry standards for quality and product performance.”
“Fluid Air is pleased to have its PolarDry technology used by an industry influencer [such as] Sferalp [and] is thrilled to have been selected as a key technology contributor to Sferalp[’s] important work,” said Michel Thenin, president, Fluid Air, in the press release.
Source: Sferalp
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.